MENU
LUNG
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Pulmonx (LUNG) Earnings Date & Reports
Pulmonx Corp is a commercial-stage medical technology company that provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD)... Show more
A.I. Advisor
published Earnings
LUNG is expected to report earnings to rise 6.67% to -25 cents per share on November 04
Q3'26
Est.
$-0.26
Q2'26
Beat
by $0.04
Q1'26
Beat
by $0.02
Q4'25
Beat
by $0.14
Q3'25
Beat
by $0.08
The last earnings report on July 29 showed earnings per share of -23 cents, beating the estimate of -28 cents. With 261.12K shares outstanding, the current market capitalization sits at 84.18M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Interesting Articles
A.I. Advisor
published General Information
General Information
Industry MedicalNursingServices
Industry
N/A
Address
700 Chesapeake Drive
Phone
+1 650 364-0400
Employees
296
Web
https://www.pulmonx.com